Back to results
US 12,569,474 B2Granted
Compositions and methods for treating anemia
AssigneeAkebia Therapeutics, Inc.
InventorsRobert Shalwitz, Charlotte Hartman, Akshay Buch, Isaiah Shalwitz, John Janusz, Joseph Gardner
Life of this patent
Estimating the term…
Abstract
Provided herein are specific doses of, and dosing regimens for, using a HIF prolyl hydroxylase inhibitor in treating or preventing anemia, such as anemia secondary to or associated with chronic kidney disease, anemia associated with or resulting from chemotherapy, or anemia associated with AIDS.
Claims16
A method for treating anemia secondary to or associated with chronic kidney disease, comprising orally administering to a patient having said anemia a once daily dose of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid,
- or a pharmaceutically acceptable salt thereof, wherein said once daily dose is 150 mg, 300 mg, 450 mg, or 600 mg of Compound 1.
Dependencies are inferred from the claim text.